Bladder Cancer Advocacy Network

What Bladder Cancer Advocacy Network does

The Bladder Cancer Advocacy Network (BCAN) is a 501(c)(3) nonprofit organization founded in 2005 and headquartered in Bethesda, Maryland, that operates as the only US national nonprofit exclusively dedicated to bladder cancer advocacy, education, support, and research. The organization serves bladder cancer patients, caregivers, survivors, and healthcare professionals through a portfolio of free resources including the Bladder Cancer Basics Handbook and Tips for Caregivers Handbook (downloadable in English and Spanish), a mobile Bladder Cancer App available on iOS and Android, an interactive Treatment Matrix, a searchable Clinical Trials Database, Bladder Cancer Resources by State, and the Bladder Cancer Matters Podcast (currently in Season 6). BCAN's support infrastructure includes a toll-free support line (833-275-4222) operated in partnership with CancerCare, an online support community of 80,000+ members, a Survivor-to-Survivor peer matching program, twice-yearly in-person summits for patients and families, and 21+ annual Walk to End Bladder Cancer events nationwide.

BCAN's revenue model is based on donations and fundraising rather than commercial sales. All resources are provided free of charge to patients, caregivers, and healthcare professionals. Funding is sourced from individual donations, grassroots fundraising (471 Walk teams raising a record $1,765,340 in 2026), grants, and corporate sponsorships anchored by Flagship pharma partners Ferring Pharmaceuticals and the Astellas/Pfizer Alliance, with EMD Serono/Pfizer supporting the Treatment Matrix. The organization operates with a 1-10 employee core team, supplementing capacity through volunteer chapters, survivor peer mentors, oncology social workers (via the CancerCare partnership), and collaborations with research bodies including Conquer Cancer, the International Bladder Cancer Group, and the World Bladder Cancer Patient Coalition.

Name

Bladder Cancer Advocacy Network

Legal name

Bladder Cancer Advocacy Network

Website

https://bcan.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

BCAN is a 501(c)(3) nonprofit and the only US national organization solely dedicated to bladder cancer advocacy, providing free education, peer support, clinical trial navigation, and research funding for the 725,000+ Americans living with the disease.

Ownership category

akta.pro rank

Product category

Nonprofit Patient Advocacy Services

NAICS

Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)

SIC

Services-Health Services (8000)

akta.pro primary industry

Community Health & Prevention Program Funding (HLAJALAF)

akta.pro secondary industry

Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)

Keywords

• Bladder cancer advocacy
• Patient education resources
• Cancer research funding
• Peer support services
• Nonprofit health organization

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Fundraising: As a 501(c)(3) nonprofit organization, BCAN relies on tax-deductible donations from supporters and fundraising activities including Walks to End Bladder Cancer. The 2026 Walk raised a record $1,765,340 with 3,730 registrants and 471 teams.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

BCAN is a national 501(c)(3) nonprofit organization that delivers free bladder cancer education, advocacy, and patient support resources to patients, survivors, caregivers, and healthcare professionals. It funds bladder cancer research through grants and convenes the community through awareness campaigns, an annual summit, and the Walk to End Bladder Cancer fundraising events. All patient-facing educational materials, peer support services, and advocacy resources are provided at no charge.

Product overview

The Bladder Cancer Advocacy Network (BCAN) is a 501(c)(3) nonprofit organization that operates as an advocacy and patient support platform rather than a commercial technology product. The organization provides a portfolio of educational resources and support services centered around four mission areas: education, support, research, and policy. The core offerings include the Bladder Cancer Basics Handbook and Tips for Caregivers Handbook (both free downloadable guides in English and Spanish), the Bladder Cancer App (mobile application for treatment exploration and clinical trial searches), the Bladder Cancer Matters Podcast (Season 6), the Survivor to Survivor peer matching program, and a toll-free support line in partnership with CancerCare. Additional resources include a Treatment Matrix for comparing options, a Clinical Trials Database, Bladder Cancer Resources by State interactive map, Survivorship Care Plans, Get the Facts fact sheets, Educational Videos/Webinars, and the annual Walk to End Bladder Cancer events. The organization does not offer a public API, does not have documented AI/ML capabilities, and functions primarily as an information and support resource rather than a technology platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Walk to End Bladder Cancer A signature national fundraising and awareness walk event series held in cities across the United States to raise funds for bladder cancer research, education, and patient support programs. Open to patients, survivors, caregivers, and supporters.
• BCAN Patient Support Line A free, nationwide telephone-based peer support service connecting bladder cancer patients and caregivers with trained survivor and caregiver volunteers for one-on-one emotional support and resource guidance.
• Patient Education Handbooks Free comprehensive patient education publications (handbooks and guides) covering bladder cancer diagnosis, treatment options, clinical trials, and survivorship, available to patients, caregivers, and healthcare professionals.
• Annual Bladder Cancer Summit An annual national conference that convenes bladder cancer patients, caregivers, clinicians, and researchers to share the latest scientific research, treatment advances, and patient advocacy updates.
• Clinical Trials Database and Treatment Options Matrix An online searchable database of bladder cancer clinical trials and a treatment options matrix that helps patients and caregivers identify available clinical trials and understand bladder cancer treatment choices.
• BCAN Podcast A podcast series featuring interviews with bladder cancer experts, researchers, patients, and caregivers discussing the disease, treatment advances, research updates, and patient experiences.
• Bladder Cancer Research Grants Competitive research grant funding awarded by BCAN to scientists and clinical investigators conducting innovative bladder cancer research.

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core, minor and flagship.

• Conquer CancercoreStrategic or Co-development Partner · 27 May 2026BCAN and Conquer Cancer jointly support innovative bladder cancer research through the Bladder Cancer Career Development Award. A $200,000 grant was awarded to Dr. Brendan Guercio in 2026 to explore how diet and the gut microbiome may improve treatment outcomes for advanced bladder cancer.
• Johnson & JohnsonminorStrategic or Co-development Partner · 14 May 2026BCAN collaborated with Johnson & Johnson and The Harris Poll on a global survey of 817 bladder cancer patients and 802 urologists examining the patient burden of current standard-of-care treatments. The survey found that over 90% of patients who underwent bladder removal surgery or BCG treatment reported significant negative impacts on physical, emotional, and mental health.
• The Harris PollminorStrategic or Co-development Partner · 14 May 2026BCAN collaborated with The Harris Poll on a global survey examining treatment burdens experienced by bladder cancer patients, released ahead of the American Urological Association Annual Meeting.
• International Bladder Cancer GroupcoreStrategic or Co-development Partner · 14 May 2026BCAN is a member of the International Bladder Cancer Group, collaborating on global patient advocacy and survey initiatives to understand the burden of bladder cancer treatments.
• World Bladder Cancer Patient CoalitioncoreStrategic or Co-development Partner · 14 May 2026BCAN collaborates with the World Bladder Cancer Patient Coalition on global patient advocacy initiatives and the international survey on bladder cancer treatment burden.
• Ferring PharmaceuticalsflagshipGTM or Marketing Partner · 1 January 2026Ferring Pharmaceuticals serves as a National Presenting Sponsor of the 2026 Walks to End Bladder Cancer, supporting awareness, research, and patient support initiatives.
• Astellas/Pfizer AllianceflagshipGTM or Marketing Partner · 1 January 2026The Astellas/Pfizer Alliance serves as a National Presenting Sponsor of the 2026 Walks to End Bladder Cancer, supporting awareness and patient advocacy efforts.
• CancerCarecoreStrategic or Co-development PartnerBCAN partners with CancerCare to operate a toll-free support line (833-275-4222) staffed by professional oncology social workers who provide emotional support, free publications, resource navigation, and referrals to bladder cancer patients, families, and the bereaved.
• EMD Serono/Pfizer AllianceminorGTM or Marketing PartnerEMD Serono/Pfizer Alliance provides support for the Bladder Cancer Treatment Matrix, helping patients and caregivers understand and compare treatment options.

Scale indicators7 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• American Cancer Society: The American Cancer Society is the largest US nonprofit dedicated to cancer broadly, funding research, patient support, and advocacy. Comparable because it is the dominant incumbent in the cancer nonprofit space against which BCAN competes for donor mindshare, despite BCAN's narrower disease focus.
• National Cancer Institute: NCI is the US federal government's principal agency for cancer research and training. Comparable as a major source of bladder cancer research funding and patient education resources against which BCAN's advocacy and research programs are positioned.
• LIVESTRONG Foundation: LIVESTRONG is a national cancer survivor-focused nonprofit providing patient navigation, education, and advocacy. Comparable as a peer cancer-support nonprofit with overlapping patient education, survivorship, and community engagement programs.

Direct peers

• Conquer Cancer: Conquer Cancer is the ASCO Foundation funding cancer research and supporting oncologists. Directly comparable because BCAN co-funds research grants with Conquer Cancer (e.g., the 2026 Bladder Cancer Career Development Award) and they share the cancer-research-funding mission.
• Prostate Cancer Foundation: PCF is a single-disease nonprofit funding prostate cancer research and providing patient education and support — directly comparable to BCAN in the single-disease cancer advocacy model, target donor profile, and research-grant funding approach.
• International Bladder Cancer Group: IBCG is an international multidisciplinary collaboration of bladder cancer experts driving research and advocacy. Comparable because BCAN is a member organization collaborating on global patient advocacy, surveys, and research initiatives.
• CancerCare: CancerCare is a national nonprofit providing free, professional support services to anyone affected by cancer, including a toll-free counseling line staffed by oncology social workers — directly comparable because BCAN partners with CancerCare to operate its bladder cancer support line, and the two share mission, target audience, and service model.
• World Bladder Cancer Patient Coalition: The World Bladder Cancer Patient Coalition is a global umbrella organization uniting bladder cancer patient groups worldwide. Directly comparable as an international peer with overlapping mission — and BCAN is itself a coalition member.
• Kidney Cancer Association: The Kidney Cancer Association is a single-disease urological cancer nonprofit providing patient education, research funding, and advocacy. Highly comparable to BCAN as a fellow urological cancer patient advocacy organization with similar structure, mission, and donor base.

Regional players

• Bladder Cancer Canada: Bladder Cancer Canada is the leading Canadian bladder cancer patient advocacy organization providing education, support, and research funding. Comparable as a peer single-disease bladder cancer nonprofit, though operating regionally in Canada rather than competing with BCAN in the US.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/b_c_a_n
• YouTubeyoutube.com/c/BladderCancerAdvocacyNetwork
• Facebookfacebook.com/bladdercancer
• LinkedInlinkedin.com/company/bladder-cancer-advocacy-network
• Instagraminstagram.com/bladdercanceradvocacynetwork

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bladder Cancer Advocacy Network